139 related articles for article (PubMed ID: 9532648)
1. [Antioxidant probucol: effects on free radical lipid peroxidation, blood rheology and course of angina pectoris].
Zakirova AN; Shamaev AG; Mirionkova NA
Ter Arkh; 1998; 70(1):29-32. PubMed ID: 9532648
[TBL] [Abstract][Full Text] [Related]
2. [Effect of probucol on cardiac electrophysiology in anginal patients with hyperlipidemia and diabetes mellitus type II].
Anikin VV; Savin VV; Lupanov VP; Razygraev RA
Ter Arkh; 2000; 72(8):28-30. PubMed ID: 11019422
[TBL] [Abstract][Full Text] [Related]
3. Indigenous free radical scavenger MAK 4 and 5 in angina pectoris. Is it only a placebo?
Dogra J; Grover N; Kumar P; Aneja N
J Assoc Physicians India; 1994 Jun; 42(6):466-7. PubMed ID: 7852231
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant treatment of therapy-resistant idiopathic membranous nephropathy with probucol: a pilot study.
Haas M; Mayer G; Wirnsberger G; Holzer H; Ratschek M; Neyer U; Neuweiler J; Kramar R; Schneider B; Breiteneder-Geleff S; Regele HM; Hörl WH; Kerjaschki D
Wien Klin Wochenschr; 2002 Feb; 114(4):143-7. PubMed ID: 12060980
[TBL] [Abstract][Full Text] [Related]
5. [The antioxidant ceruloplasmin: its effect on lipid peroxidation, blood rheology and the course of stenocardia].
Zakirova AN; Mingazetdinova LN; Kamilov FKh; Lankin VZ; Lebedev AV; Konovalova GG
Ter Arkh; 1994; 66(9):24-8. PubMed ID: 7992206
[TBL] [Abstract][Full Text] [Related]
6. [The effect of phenol antioxidants on the development of alloxan diabetes in rats].
Bobyreva LE
Eksp Klin Farmakol; 1997; 60(3):51-3. PubMed ID: 9324400
[TBL] [Abstract][Full Text] [Related]
7. [The antioxidant probucol as a regulator of the intensity of free-radical lipid peroxidation processes in the blood of patients with coronary atherosclerosis].
Tikhaze AK; Lankin VZ; Mikhin VP; Revenko VM; Lupanov VP
Ter Arkh; 1997; 69(9):35-41. PubMed ID: 9411823
[TBL] [Abstract][Full Text] [Related]
8. The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia.
Koter M; Broncel M; Chojnowska-Jezierska J; Klikczynska K; Franiak I
Eur J Clin Pharmacol; 2002 Nov; 58(8):501-6. PubMed ID: 12451426
[TBL] [Abstract][Full Text] [Related]
9. [Long-term effects of captopril treatment on the course of stable effort angina pectoris and structural-functional characteristics of platelets in patients with hypertension and ischemic heart disease].
Shafer MZh; Gul'tiaeva EP; Gapon LI; Alfimova TV
Ter Arkh; 2001; 73(7):64-7. PubMed ID: 11523414
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
[TBL] [Abstract][Full Text] [Related]
11. [The antioxidant histochrome: its effect on lipid peroxidation and the blood rheological properties in patients with unstable stenocardia].
Zakirova AN; Lebedev AV; Kukharchuk VV; Mishchenko NP; Fedoreev SA
Ter Arkh; 1996; 68(8):12-4. PubMed ID: 9019822
[TBL] [Abstract][Full Text] [Related]
12. Ceftriaxone induced lipid peroxidation and its inhibition with various antioxidants: Part II. Evaluation of glutathione and probucol as antioxidants.
Roy K; Saha A; De K; Sengupta C
Acta Pol Pharm; 2000; 57(5):385-90. PubMed ID: 11126031
[TBL] [Abstract][Full Text] [Related]
13. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo].
Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV
Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741
[No Abstract] [Full Text] [Related]
14. Evaluation of alpha-tocopherol, probucol and ascorbic acid as suppressors of digoxin induced lipid peroxidation.
De K; Roy K; Saha A; Sengupta C
Acta Pol Pharm; 2001; 58(5):391-400. PubMed ID: 11876447
[TBL] [Abstract][Full Text] [Related]
15. [The correlations of lipid peroxidation, antioxidant protection and microrheological disorders in the development of IHD].
Zakirova AN
Ter Arkh; 1996; 68(9):37-40. PubMed ID: 9005610
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of probucol as suppressor of ceftizoxime induced lipid peroxidation.
Roy K; Saha A; De K; Sengupta C
Acta Pol Pharm; 2002; 59(3):231-4. PubMed ID: 12230252
[TBL] [Abstract][Full Text] [Related]
17. [The effect of histochrome on the lipid peroxidation indices during the surgical treatment of patients with ischemic heart disease of different functional classes].
Afanas'ev SA; Lasukova TV; Cherniavskiĭ AM; Vecherskiĭ IuIu; Ponomarenko IV
Eksp Klin Farmakol; 1999; 62(6):32-4. PubMed ID: 10650524
[TBL] [Abstract][Full Text] [Related]
18. [The role of lipid peroxides and blood rheological disorders in the pathogenesis and clinical course of ischemic heart disease].
Mingazetdinova LN; Zakirova AN; Lankin VZ
Ter Arkh; 1993; 65(8):12-5. PubMed ID: 8211792
[TBL] [Abstract][Full Text] [Related]
19. [Effect of probucol on lipid metabolism and the clinical course of ischemic heart disease and arteriosclerosis obliterans of the vessels of the lower extremities].
Dudaev VA; Gorin VV; Shingireĭ MV; Kliuchnikova ZhI; Diukov IV
Kardiologiia; 1984 Jun; 24(6):76-9. PubMed ID: 6748497
[TBL] [Abstract][Full Text] [Related]
20. [Dipyridamole (curantil) treatment of anginal patients: results of treatment for many years].
Anikin VV
Ter Arkh; 1999; 71(8):34-7. PubMed ID: 10515033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
